Search

Your search keyword '"Khan, Mehmood"' showing total 4 results
Start Over Author "Khan, Mehmood" Publisher american diabetes association
4 results on '"Khan, Mehmood"'

1. Pioglitazone and rosiglitazone have different effects on serum lipoprotein particle concentrations and sizes in patients with type 2 diabetes and dyslipidemia

Author

Deeg, Mark A., Buse, John B., Goldberg, Ronald B., Kendall, David M., Zagar, Anthony J., Jacober, Scott J., Khan, Mehmood A., Perez, Alfonzo T., and Tan, Meng H.

Subjects
Rosiglitazone maleate -- Evaluation -- Dosage and administration -- Physiological aspects, Blood lipoproteins -- Evaluation -- Physiological aspects, Type 1 diabetes -- Drug therapy, Proteolipids -- Evaluation -- Physiological aspects, Hyperlipidemia -- Drug therapy, Lipoproteins -- Evaluation -- Physiological aspects, Health, Drug therapy, Evaluation, Physiological aspects, Dosage and administration
Abstract

OBJECTIVE--Associated with insulin resistance in type 2 diabetes are increased serum triglycerides, decreased HDL cholesterol, and a predominance of large VLDL, small LDL, and small HDL particles. The comparative effects [...]

Published
2007

2. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia

Author

Goldberg, Ronald B., Kendall, David M., Deeg, Mark A., Buse, John B., Zagar, Anthony J., Pinaire, Jane A., Tan, Meng H., Khan, Mehmood A., Perez, Alfonso T., and Jacober, Scott J.

Subjects
Diabetes -- Case studies -- Physiological aspects, Hypoglycemic agents -- Physiological aspects -- Case studies, Lipid metabolism -- Case studies -- Physiological aspects, Type 2 diabetes -- Case studies -- Physiological aspects, Health, Physiological aspects, Case studies
Abstract

OBJECTIVE--Published reports suggest that pioglitazone and rosiglitazone have different effects on lipids in patients with type 2 diabetes. However, these previous studies were either retrospective chart reviews or clinical trials [...]

Published
2005

3. A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone. (Emerging Treatment Technologies)

Author

Khan, Mehmood A., St. Peter, John V., and Xue, Jay L.

Subjects
Lipids, Troglitazone -- Evaluation, Diabetes -- Research, Glucose metabolism, Thiazolidinediones -- Evaluation, Health, Evaluation
Abstract

OBJECTIVE -- To characterize potential differences in glycemic control, plasma lipid level, and weight in a cohort of patients previously treated with troglitazone (TROG) who were switched to either pioglitazone [...]

Published
2002

4. Diabetes Disease Stage Predicts Weight Loss Outcomes with Long-term Appetite Suppressants

Author

KHAN, MEHMOOD A, ST. PETER, JOHN V, BREEN, GAIL A, HARTLEY, GUILFORD G, and VESSEY, JOHN T

Subjects
Diabetes -- Research, Health
Abstract

The UKPDS demonstrates that almost all obese Type 2 diabetics progress from diet control alone to requiring drug therapy, indicating progressive decline in both [Beta]-cell function and insulin sensitivity. Rate [...]

Published
1999

Catalog

Books, media, physical & digital resources
See catalog results